SEAN PATRICK CONSIDINE MD
Prescription History 1861029068
Ophthalmology in Wilmington, DE
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for SEAN PATRICK CONSIDINE MD, an active Ophthalmology specialist practicing in Wilmington, DE. Our medical registry currently tracks 7 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 223 documented patient claims. Among these therapy options, the most frequently utilized medication is Latanoprost, which accounts for 73 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other DE PrescribersVs. DE Avg |
|---|---|---|---|
| Latanoprost | 73 | $9.84▼ below DE avg | ▼ Less than typical |
About Latanoprost: Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (such as ocular hypertension). Show more ▾ It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness. A prostaglandin F analog used to treat OCULAR HYPERTENSION in patients with GLAUCOMA. In 2024, this provider wrote 73 Medicare prescriptions for Latanoprost, about half the volume of the typical Delaware prescriber of this medication (134.5). Medicare paid an average of $9.84 per fill, versus $15.23 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average DE prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the DE average for this medication. 132.4 30-Day Fills standardized to 30-day supplies 3,792 Days of Medication total across all patients in 2024 | |||
| Prednisolone Acetate | 49 | $44.30 | ▼ Less than typical |
About Prednisolone Acetate: This medication is used to treat certain eye conditions due to inflammation or injury. Show more ▾ Prednisolone works by relieving symptoms such as swelling, redness, and itching. It belongs to a class of drugs known as corticosteroids. A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states. In 2024, this provider wrote 49 Medicare prescriptions for Prednisolone Acetate, about half the volume of the typical Delaware prescriber of this medication (103.7). Medicare paid an average of $44.30 per fill, versus $40.56 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average DE prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 74.8 30-Day Fills standardized to 30-day supplies 2,080 Days of Medication total across all patients in 2024 | |||
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 30 | $28.27 | ▼ Less than typical |
About Dorzolamide-Timolol: This product contains two drugs used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers, and dorzolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. In 2024, this provider wrote 30 Medicare prescriptions for Dorzolamide-Timolol, about a third of the volume of the typical Delaware prescriber of this medication (80.2). Medicare paid an average of $28.27 per fill, versus $18.06 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average DE prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 72.6 30-Day Fills standardized to 30-day supplies 2,178 Days of Medication total across all patients in 2024 | |||
| Brimonidine Tartrate | 21 | $9.20▼ below DE avg | ▼ Less than typical |
About Brimonidine Tartrate: This medication is used to treat open-angle glaucoma or high fluid pressure in the eye. Show more ▾ Lowering high fluid pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This medication lowers pressure by allowing better fluid drainage from within the eye and also by reducing the amount of fluid formed in the eye. It is known as an alpha agonist. This drug is not recommended for use in children less than 2 years of age due to an increased risk of serious side effects such as very slowed breathing. Ask the doctor or pharmacist for details. A quinoxaline derivative and ADRENERGIC ALHPA-2 RECEPTOR AGONIST that is used to manage INTRAOCULAR PRESSURE associated with OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2024, this provider wrote 21 Medicare prescriptions for Brimonidine Tartrate, about a third of the volume of the typical Delaware prescriber of this medication (58.5). Medicare paid an average of $9.20 per fill, versus $58.61 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average DE prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the DE average for this medication. 48.5 30-Day Fills standardized to 30-day supplies 1,400 Days of Medication total across all patients in 2024 | |||
| Diclofenac Sodium | 19 | $7.46▼ below DE avg | ▼ Less than typical |
About Diclofenac Sodium: See also Warning section. Show more ▾ This medication is used to relieve joint pain from arthritis. Diclofenac belongs to a class of drugs known as nonsteroidal anti-inflammatory drugs (NSAIDs). If you are treating a chronic condition such as arthritis, ask your doctor about non-drug treatments and/or using other medications to treat your pain. A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt. In 2024, this provider wrote 19 Medicare prescriptions for Diclofenac Sodium, about half the volume of the typical Delaware prescriber of this medication (31.9). Medicare paid an average of $7.46 per fill, versus $34.27 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average DE prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the DE average for this medication. 19.7 30-Day Fills standardized to 30-day supplies 489 Days of Medication total across all patients in 2024 | |||
| Atropine Sulfate | 16 | $30.71▼ below DE avg | ▼ Less than typical |
About Atropine Sulfate: This medication is used before eye examinations (such as refraction) and to treat certain eye conditions (such as uveitis). Show more ▾ It belongs to a class of drugs known as anticholinergics. Atropine works by widening (dilating) the pupil of the eye. An alkaloid, originally from Atropa belladonna, but found in other plants, mainly SOLANACEAE. Hyoscyamine is the 3(S)-endo isomer of atropine. In 2024, this provider wrote 16 Medicare prescriptions for Atropine Sulfate, about half the volume of the typical Delaware prescriber of this medication (27.1). Medicare paid an average of $30.71 per fill, versus $38.39 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average DE prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the DE average for this medication. 19.8 30-Day Fills standardized to 30-day supplies 505 Days of Medication total across all patients in 2024 | |||
| Ketorolac Tromethamine | 15 | $20.09 | ▼ Less than typical |
About Ketorolac Tromethamine: This medication is used to temporarily relieve itching eyes caused by seasonal allergies. Show more ▾ It is also used to prevent and treat eye swelling due to a certain type of eye surgery (cataract removal). Ketorolac belongs to a class of drugs known as nonsteroidal anti-inflammatory drugs (NSAIDs). It works by blocking certain natural substances in your body to reduce pain and swelling. A pyrrolizine carboxylic acid derivative structurally related to INDOMETHACIN. It is a non-steroidal anti-inflammatory agent used for analgesia for postoperative pain and inhibits cyclooxygenase activity. In 2024, this provider wrote 15 Medicare prescriptions for Ketorolac Tromethamine, about 14% of the volume of the typical Delaware prescriber of this medication (107.7). Medicare paid an average of $20.09 per fill, versus $19.06 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average DE prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 19.6 30-Day Fills standardized to 30-day supplies 515 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for SEAN PATRICK CONSIDINE MD is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Ophthalmology prescribing approach at this Wilmington, DE practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among DE prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
